118th Congress Health
S. 1852: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023
Reported
- Introduced (completed)
- Passed Senate (not reached)
- Passed House (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill reauthorizes through FY2028 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve treatment and prevention of sickle cell disease and complications from that disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Cory Booker D-NJOriginal
- Raphael Warnock D-GA
Who scored on this bill
- 1Tim Scott SponsorDrew cross-party cosponsors, introduced, reported3 events+26
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Tim Scott
- S. 2301: Improving Care in Rural America Reauthorization Act of 2025
- S. 2651: ROAD to Housing Act of 2025
- S.J.Res. 18: Disapproving the rule submitted by the Bureau of Consumer Financial Protection relating to "Overdraft Lending: Very Large Financial Institutions"
- S. 875: FIRM Act
- S. 371: SBA Disaster Transparency Act
- S. 1271: FEND Off Fentanyl Act
History
- Introduced in the Senate by Tim Scott.
Show the full action history (5 actions)
- Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders without amendment. Without written report.
- Placed on Senate Legislative Calendar under General Orders. Calendar No. 201.
- Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
- Introduced in Senate
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.